Professional Documents
Culture Documents
BREAST - Doc Wenceslao
BREAST - Doc Wenceslao
PE: characterized the mass (3x4 cm mass UQ, 6cm from nipple)
- BRACA mutations
- BRACA 1- assoc. with breast and ovarian CA, and colon CA. (Poorly differentiated)
- You can do sampling, bilateral mastectomy, surveillance of siblings, (MRI have more advantage
than mammogram. Young patient don’t request mammogram because their breast are dense.
MRI 20-25% risk of breast CA.). The accuracy of mammogram decreases in young pt.
- Tamoxifen; hormonal therapy
- Postmenopausal hormonal therapy: aromatase inhibitors- more effective than tamoxifen.
- Risk reduction surgery (reduce risk >90%)
- Bilateral salphingo-oophorectomy 35-40yr old; child bearing
- Increase bilaterally and motility of mass (if BRCA)
Management:
RECEPTOR ASSAY
ER ++ in 95% of tumor cells
PR++ in 80% of tumor cells
Her2 neu- receptor
Ki- 67 + (>10%): dictates what chemotherapeutic agent is concerned.
Genomic subtypes of Breast CA:
Luminal A- responsive in hormonal therapy
Luminal B- responsive in chemotherapy
STAGING:
- (Pt. stage T2, NO,MO) are you going to do breast work up? Stage 2A- early Breast CA)
#just2letters💕